Contact Person : Prof. K.P.M.S.V. Padmasree ; Last Date for the submission of abstract : 25/11/2017; Indian pharma is transforming with biotech portfolio in development of biologicals in both biosimilar and novel molecules. The strong IT base, state of the art infrastructure and large pool of scientic power can be exploited for the design and development of innovative therapeutics.